US 8,115,804 · Application 11/622,681 · Granted Feb 14, 2012
US 8,115,804
Processing multiview video
Estimated expiration
December 2, 2030
4y 81d remaining
Earliest effective filing
Jan 12, 2007
+ 20 years
Jan 12, 2027
PTA +1420d
Dec 2, 2030
No TD
—
Final
Dec 2, 2030
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- January 12, 2007
- Earliest effective filing
- January 12, 2007
- Issue date
- February 14, 2012
- PTA
- +1420 days
- Base expiry (before PTA)
- January 12, 2027
January 12, 2007 + 20 years = January 12, 2027 + 1420 PTA days = December 2, 2030
- PRO60/758,234 — Provisional — not used for base term
- PRO60/759,620 — Provisional — not used for base term
- PRO60/762,534 — Provisional — not used for base term
- PRO60/787,193 — Provisional — not used for base term
- PRO60/818,274 — Provisional — not used for base term
- PRO60/830,087 — Provisional — not used for base term
- PRO60/830,328 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 11/622,681 · US 8,115,804
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 8,115,804: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US8115804Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.